Tag results:
MYC
Cancer Stem Cell News
Methionine Restriction Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Stem Cells by miR-320d/C-myc Axis
[Molecular and Cellular Biochemistry] The combined chemotherapy with methionine restriction could enhance the chemotherapeutic sensitivity of colorectal cancer stem cells by up-regulation of miR-320d to inhibit c-Myc expression
Prostate Cell News
TMPRSS2-ERG Promotes the Initiation of Prostate Cancer by Suppressing Oncogene-Induced Senescence
[Cancer Gene Therapy] In primary prostate luminal epithelial cells, following inducible oncogenic Kras expression or Pten depletion, TMPRSS2-ERG suppressed oncogene-induced senescence, independent of TP53 induction and RB1 inhibition.
Immune Regulation News
IP3R-Mediated Ca2+ Signaling Controls B Cell Proliferation through Metabolic Reprogramming
[iScience] Investigators demonstrated that IP3R-mediated Ca2+ signaling and calcineurin regulated B cell proliferation and survival by activating metabolic reprogramming in response to B cell receptor stimulation.
Pulmonary Cell News
USP28 Enables Oncogenic Transformation of Respiratory Cells and Its Inhibition Potentiates Molecular Therapy Targeting Mutant EGFR, BRAF and PI3K.
[Molecular Oncology] Targeting ubiquitin carboxyl-terminal hydrolase 28 (USP28) protein abundance at an early stage via inhibition of its activity is a feasible strategy for the treatment of early-stage lung tumors.
Cancer Stem Cell News
MiR-222-3p Inhibits Formation of Medulloblastoma Stem-Like Cells by Targeting Notch2/C-myc Signaling Pathway
[Immunopharmacology and Immunotoxicology] Scientists investigated the effects of miR-222-3p on the formation of medulloblastoma stem-like cells via the Notch2/c-myc pathway.
Pulmonary Cell News
Targeting Nicotinamide N-Methyltransferase Overcomes Resistance to EGFR-TKI in Non-Small Cell Lung Cancer Cells
[Cell Death Discovery] Using iTRAQ-based quantitative proteomics analysis, we identified that nicotinamide N-methyltransferase was significantly increased in epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI)-resistant NSCLC cells.